What just happened? TSMC has begun volume production of chips based on its N2 process technology, marking a major new step in 2nm-class node manufacturing. The company disclosed the milestone on its ...
A crucial stage in the growth of Norwegian-based electrolyser company, Nel, has been reached as its board approved massive expansion plans for next-generation technology. This comes after seven years ...
A Durham-based project had a $285 million contract terminated by the federal government, according to a spokesperson. Smart USA Institute learned it was losing the federal funding on Dec. 10. The ...
The development of lithium-7 fluoride production technology is seen as a key step in Russia for the proposed future molten salt reactors. (Image: Rosatom) There is currently no industrial production ...
The U.S. Food and Drug Administration plans to change how COVID vaccines and other shots are approved and administered. The memo, which was written by FDA chief medical and scientific officer Vinay ...
A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging that COVID-19 vaccination resulted in the deaths of 10 children.Video above: ...
The agency pointed to its analysis of 96 deaths allegedly linked to the COVID-19 vaccine for the changes. Reagan judges surface as unfiltered assessors of Trump Julia Roberts Celebrates Twins’ ...
The road to getting a sequel to 2022's The Batman has been complex and long. Fortunately, the film is finally taking shape under the watchful eye of returning director Matt Reeves. Starring Robert ...
According to a post shared by an X (formerly Twitter) fan page that regularly shares updates related to Timothée Chalamet, the leading star of Dune, production on the third part has now concluded.
WASHINGTON/PARIS, Nov 7 (Reuters) - Democratic Republic of Congo and Rwanda said in a statement on Friday that they had agreed an economic pact in Washington, as U.S. President Donald Trump seeks to ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...